Aller au contenu principal
Profil bibliographique

Weiguo Cao

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

448Publications signalées
7410Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Fluorine in Organic ChemistryCyclopropane Reaction MechanismsAsymmetric Synthesis and CatalysisSynthesis and Biological EvaluationSynthetic Organic Chemistry Methods

Les publications récentes

Accès ouvert 2026 article OpenAlex

Adsorption performance and mechanism of MgAl-LDHs@FRBCs/Fe 3 O 4 composite for multiple heavy metal ions in the aqueous extract of Ligusticum chuanxiong Hort

Jinxin Fang, Hong‐Li Guo, Chenling Xu, S Y Wang et autres

) confirmed a spontaneous and endothermic process with increased disorder. Further mechanism investigation by pH-dependent experiments, zeta potential measurements, and XPS revealed that the adsorption occurred mainly through electrostatic interactions and chemical complexation. Importantly, HPLC analysis revealed no significant alteration of the …

cn (code pays fourni par la source)

0 citations RSC Advances
2025 article OpenAlex

Photocatalytic Dual-Defluorination Thiolation of Trifluoromethyl Hydrazones

Wenjie Pan, Weiguo Cao, Ji‐Chang Xiao, Jin‐Hong Lin

The defluorination of trifluoromethyl groups typically involves breaking one or all three C-F bonds, while selectively cleaving exactly two C-F bonds presents a considerable challenge. In this work, we present a method for the sequential defluorination of trifluoromethyl hydrazones under photocatalytic conditions, …

cn, us (code pays fourni par la source)

1 citation Organic Letters
Accès ouvert 2025 article OpenAlex

Response‐adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T‐cell therapy in relapsed/refractory large B‐cell lymphoma: A retrospective observational study

Rong Shen, Weiguo Cao, Wang Li, Lingshuang Sheng et autres

BACKGROUND: CD19 chimeric antigen receptor (CAR) T-cell therapy is a potential treatment for relapsed/refractory (R/R) large B-cell lymphoma (LBCL). The combination of targeted therapeutic strategies, particularly bruton tyrosine kinase inhibitor zanubrutinib and programmed death-1 inhibitor tislelizumab, may improve clinical outcomes and modulate …

cn (code pays fourni par la source)

4 citations Clinical and Translational Medicine
Accès ouvert 2025 article OpenAlex

Clinicopathological Features of Diffuse Hemispheric Glioma, H3G34-Mutant

Juan Cao, Yongxian Chen, Guocheng Yang, Xiaoxiao He et autres

OBJECTIVE: To investigate the clinical manifestations, radiographic features, and pathological characteristics of three cases of diffuse hemispheric gliomas, H3G34-mutant (H3G34 DHG). METHODS: This study used a single-center retrospective cohort approach to analyze 45 pediatric-type diffuse high-grade glioma cases. RESULTS: Histologically, case 1 …

cn (code pays fourni par la source)

1 citation Fetal and Pediatric Pathology
Accès ouvert 2025 article OpenAlex

Photo‐Induced 3‐Alkylation of Coumarins with Alkyl Halides

Yan Cheng, Liu‐Yan Qiu, Rui Wang, Weiguo Cao et autres

Abstract A method for the direct 3‐alkylation of coumarins utilizing alkyl halides as the alkylating agents has been achieved. This versatile reaction is compatible with a range of alkyl halides, including activated alkyl bromides, perfluoroalkyl iodides, and unactivated alkyl iodides. We propose …

cn (code pays fourni par la source)

4 citations Advanced Synthesis & Catalysis
Accès ouvert 2024 article OpenAlex

Toripalimab combined with definitive chemoradiotherapy for locally advanced cervical squamous cell carcinoma patients (TRACE): A single-arm, phase I/II trial

Dan Ou, Rong Cai, Wei-Xiang Qi, Can Cui et autres

PURPOSE: This phase I/II trial (ChiCTR2000032879) assessed the safety and efficacy of toripalimab combined with chemoradiotherapy for locally advanced cervical squamous cell carcinoma. METHODS AND MATERIALS: , once weekly for 5 weeks), radiotherapy (45-50.4 Gy/25-28 Fx, 5 fractions weekly), followed by brachytherapy …

cn, us (code pays fourni par la source)

5 citations Cancer Immunology Immunotherapy

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.